Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine maintenance in resected solid tumors
NCT03015324Phase 1Completed
- Start
- Aug 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of hydroxychloroquine in solid tumor. Primary endpoint: PAR-4 increase at 3 months. Started Aug 2017; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03015324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03015324.